|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0003364,
umls-concept:C0008976,
umls-concept:C0011849,
umls-concept:C0015663,
umls-concept:C0017725,
umls-concept:C0027051,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0441889,
umls-concept:C0456387,
umls-concept:C0684224,
umls-concept:C1514756,
umls-concept:C1551358
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2006-11-14
|
|
pubmed:abstractText |
Elevated blood glucose levels are reported with thiazide-type diuretic treatment of hypertension. The significance of this finding is uncertain. Our objectives were to compare the effect of first-step antihypertensive drug therapy with thiazide-type diuretic, calcium-channel blocker, or angiotensin-converting enzyme inhibitor on fasting glucose (FG) levels and to determine cardiovascular and renal disease risks associated with elevated FG levels and incident diabetes mellitus (DM) in 3 treatment groups.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
pubmed-author:ALLHAT Collaborative Research Group,
pubmed-author:BarzilayJoshua IJI,
pubmed-author:BasileJanJ,
pubmed-author:CutlerJeffrey AJA,
pubmed-author:DavisBarry RBR,
pubmed-author:MargolisKaren LKL,
pubmed-author:OngStephen TST,
pubmed-author:PresselSara LSL,
pubmed-author:SadlerLaurie SLS,
pubmed-author:SummersonJohnJ,
pubmed-author:WheltonPaul KPK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
13
|
|
pubmed:volume |
166
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2191-201
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:17101936-Aged,
pubmed-meshheading:17101936-Amlodipine,
pubmed-meshheading:17101936-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:17101936-Antihypertensive Agents,
pubmed-meshheading:17101936-Blood Glucose,
pubmed-meshheading:17101936-Calcium Channel Blockers,
pubmed-meshheading:17101936-Chi-Square Distribution,
pubmed-meshheading:17101936-Chlorthalidone,
pubmed-meshheading:17101936-Diabetes Mellitus,
pubmed-meshheading:17101936-Female,
pubmed-meshheading:17101936-Humans,
pubmed-meshheading:17101936-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:17101936-Hyperlipidemias,
pubmed-meshheading:17101936-Hypertension,
pubmed-meshheading:17101936-Incidence,
pubmed-meshheading:17101936-Lisinopril,
pubmed-meshheading:17101936-Male,
pubmed-meshheading:17101936-Middle Aged,
pubmed-meshheading:17101936-Myocardial Infarction,
pubmed-meshheading:17101936-Proportional Hazards Models,
pubmed-meshheading:17101936-Sodium Chloride Symporter Inhibitors,
pubmed-meshheading:17101936-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
|
pubmed:affiliation |
Kaiser Permanente of Georgia , USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
